Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Biochem Med (Zagreb) ; 25(3): 335-58, 2015.
Article in English | MEDLINE | ID: mdl-26524965

ABSTRACT

Capillary blood sampling is a medical procedure aimed at assisting in patient diagnosis, management and treatment, and is increasingly used worldwide, in part because of the increasing availability of point-of-care testing. It is also frequently used to obtain small blood volumes for laboratory testing because it minimizes pain. The capillary blood sampling procedure can influence the quality of the sample as well as the accuracy of test results, highlighting the need for immediate, widespread standardization. A recent nationwide survey of policies and practices related to capillary blood sampling in medical laboratories in Croatia has shown that capillary sampling procedures are not standardized and that only a small proportion of Croatian laboratories comply with guidelines from the Clinical Laboratory Standards Institute (CLSI) or the World Health Organization (WHO). The aim of this document is to provide recommendations for capillary blood sampling. This document has been produced by the Working Group for Capillary Blood Sampling within the Croatian Society of Medical Biochemistry and Laboratory Medicine. Our recommendations are based on existing available standards and recommendations (WHO Best Practices in Phlebotomy, CLSI GP42-A6 and CLSI C46-A2), which have been modified based on local logistical, cultural, legal and regulatory requirements. We hope that these recommendations will be a useful contribution to the standardization of capillary blood sampling in Croatia.


Subject(s)
Biochemistry/organization & administration , Blood Specimen Collection/standards , Medical Laboratory Science/organization & administration , Societies, Scientific/standards , Blood Specimen Collection/methods , Capillaries , Containment of Biohazards/standards , Croatia , Disinfection/methods , Disinfection/standards , Gloves, Protective , Hand Disinfection , Humans , Infection Control/methods , Infection Control/standards , Organ Specificity , Patient Identification Systems
2.
Lijec Vjesn ; 133(1-2): 39-50, 2011.
Article in Croatian | MEDLINE | ID: mdl-21644278

ABSTRACT

Vitamin B12 (cobalamin) has two active forms, adenosylcobalamin and methylcobalamin which have a key role in two important metabolic pathways in humans and their deficiency is responsible for clinical problems. Cobalamin is essential during whole life, but its sufficient amount is extra important in fetal and neonatal period, when it is essential for normal child growth and development as well as for normal development of the central nervous system. Because of very complex transport and metabolism, its deficiency can be manifested in numerous congenital and acquired disorders. Vitamin B12 deficiency mostly has non-specific clinical features, it carries a great risk of permanent consequences, but most frequently it is easily curable if diagnosed on time. In Croatia cobalamin deficiency in children has been diagnosed too rarely. Accordingly, the aim of this paper is to point to the recently gained knowledge on cobalamin metabolism, present typical case reports and to provide guidelines for rapid and proper diagnostic and therapeutic approach.


Subject(s)
Vitamin B 12 Deficiency/complications , Female , Humans , Infant , Infant, Newborn , Male , Vitamin B 12/metabolism , Vitamin B 12 Deficiency/diagnosis
3.
Lijec Vjesn ; 125(11-12): 312-6, 2003.
Article in Croatian | MEDLINE | ID: mdl-15209027

ABSTRACT

Glutaric aciduria type 1 (GA 1) is a preventable cause of acute brain damage in early childhood, leading to a severe dystonic-dyskinetic disorder. Typically between 6 and 18 months of age, a non-specific illness such as respiratory or gastrointestinal infection or immunization leads to encephalopathic crisis, usually resulting in degeneration of the putamen and caudate. GA 1 is an autosomal recessive disease of catabolism of amino acids lysine, hydroxylysine and tryptophane leading to accumulation of glutaric acid, 3-hydroxyglutaric acid and glutaconic acid. Recognition of this biochemical disorder before the brain has been injured is essential to the outcome. Diagnosis depends upon the recognition of relatively non-specific physical findings such as hypotonia, tremor, irritability and macrocephaly, and on urinary organic acids analysis. The diagnosis may also be suggested by characteristic findings of neuroimaging. Specific management includes pharmacological doses of 1-carnitine and dietary protein restriction. Metabolic decompensation must be treated vigorously to avoid permanent brain damage. With this case report the authors want to contribute to the early recognition of GA1, to the prevention of the related brain damage, and to increase awareness of the existence of so-called cerebral organic acidurias.


Subject(s)
Amino Acid Metabolism, Inborn Errors/diagnosis , Glutarates/urine , Amino Acid Metabolism, Inborn Errors/complications , Amino Acid Metabolism, Inborn Errors/metabolism , Amino Acid Metabolism, Inborn Errors/therapy , Brain Damage, Chronic/etiology , Brain Damage, Chronic/prevention & control , Diagnosis, Differential , Humans , Hydroxylysine/metabolism , Infant , Lysine/metabolism , Male , Tryptophan/metabolism
4.
Am J Med Genet ; 111(3): 271-84, 2002 Aug 15.
Article in English | MEDLINE | ID: mdl-12210323

ABSTRACT

Primary systemic carnitine deficiency or carnitine uptake defect (OMIM 212140) is a potentially lethal, autosomal recessive disorder characterized by progressive infantile-onset cardiomyopathy, weakness, and recurrent hypoglycemic hypoketotic encephalopathy, which is highly responsive to L-carnitine therapy. Molecular analysis of the SLC22A5 (OCTN2) gene, encoding the high-affinity carnitine transporter, was done in 11 affected individuals by direct nucleotide sequencing of polymerase chain reaction products from all 10 exons. Carnitine uptake (at Km of 5 microM) in cultured skin fibroblasts ranged from 1% to 20% of normal controls. Eleven mutations (delF23, N32S, and one 11-bp duplication in exon 1; R169W in exon 3; a donor splice mutation [IVS3+1 G > A] in intron 3; frameshift mutations in exons 5 and 6; Y401X in exon 7; T440M, T468R and S470F in exon 8) are described. There was no correlation between residual uptake and severity of clinical presentation, suggesting that the wide phenotypic variability is likely related to exogenous stressors exacerbating carnitine deficiency. Most importantly, strict compliance with carnitine from birth appears to prevent the phenotype.


Subject(s)
Cardiomyopathies/prevention & control , Carnitine/pharmacology , Carrier Proteins/genetics , Heart/drug effects , Membrane Proteins/genetics , Organic Cation Transport Proteins , Carnitine/deficiency , Child , Child, Preschool , Female , Humans , Male , Mutation , Pedigree , Solute Carrier Family 22 Member 5 , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...